Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 415 Both allogeneic and syngen...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
415 Both allogeneic and syngeneic induced pluripotent stem cell (iPSC) vaccines decrease tumor growth and improve survival in a prophylactic mouse model of breast cancer

415 Both allogeneic and syngeneic induced pluripotent stem cell (iPSC) vaccines decrease tumor growth and improve survival in a prophylactic mouse model of breast cancer

Bibliographic Details
Main Authors: Matthias Hundt, Ivan Hernandez, Pratima Kundu, Sahil Inamdar, Carlos A Obejero-Paz, Nigel G Kooreman, Stephen D Wolpe, Lynne A Bui, Skylar R Foust
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • 414 Efficacy and immunogenicity of induced pluripotent stem cell (iPSC) vaccine is independent of iPSC viability in a prophylactic mouse model of breast cancer
    by: Hui Huang, et al.
    Published: (2023-11-01)
  • 775 An induced pluripotent stem cell (iPSC) vaccine decreases tumor growth and improves survival in a therapeutic mouse model of colon cancer
    by: Matthias Hundt, et al.
    Published: (2021-11-01)
  • 774 An induced pluripotent stem cell (iPSC) vaccine is highly immunogenic and reduces lung metastases in a mouse model of melanoma
    by: Matthias Hundt, et al.
    Published: (2021-11-01)
  • Studies on immune regulation for allogeneic iPSC-based transplantation
    by: Ken-ichiro Seino
    Published: (2022-12-01)
  • Role of Cytokines and Growth Factors in the Manufacturing of iPSC-Derived Allogeneic Cell Therapy Products
    by: Chen-Yuan Kao, et al.
    Published: (2023-05-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs